What's new

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised

Jun 4, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Spexotras, trametinib,...

Next Article

Medicines during pregnancy and breastfeeding

Related Posts

EMEA-003537-PIP01-23

EMEA-003537-PIP01-23

Jun 6, 2025  0

EMEA-002338-PIP05-23

EMEA-002338-PIP05-23

Jun 24, 2025  0

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0